Skip to main content

Series B Biotechnology Companies

Explore 427 biotechnology startups that raised series b funding. Access verified founder contact information and fundraising data.

Total Companies
427
Total Funding
$1.2B
Avg Funding
$48.6M
Cities
22

Export 427 Series B Biotechnology Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Alameda, United States

Magnetic Insight is a biotechnology company that offers cellular imaging to measure the efficacy of cancer immunotherapies.

Jul 2024
Series B

Founder Contacts

41,000+ verified contacts

Genive, Switzerland
$85.7M
raised

iOnctura is a clinical-stage biotechnology company that specializes in developing treatments for cancer.

Jun 2024
Series B

Founder Contacts

41,000+ verified contacts

Alameda, United States
$125.0M
raised

Santa Ana Bio is a biotechnology company focusing on precision immunology for autoimmune and inflammatory diseases.

Jun 2024
Series B

Founder Contacts

41,000+ verified contacts

Emeryville, United States
$55.0M
raised

Prolific Machines unlocks production of next-generation therapeutics with a light-controlled gene expression system and closed-loop control.

Jun 2024
Series B

Founder Contacts

41,000+ verified contacts

Adelaide, Australia
$12.0M
raised

GPN Vaccines is a vaccine that is used to prevent the spread of streptococcus pneumoniae.

Jun 2024
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 427 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Long Island City, United States
$25.0M
raised

Envisagenics reduce the complexity of biomedical data to accelerate the development of innovative therapeutic solutions.

Jun 2024
Series B

Founder Contacts

41,000+ verified contacts

Philadelphia, United States
$51.4M
raised

Interius BioTherapeutics is a biopharmaceutical company that develops in vivo cell-specific gene medicines to treat B cell lymphomas.

Jun 2024
Series B

Founder Contacts

41,000+ verified contacts

Cincinnati, United States
$73.0M
raised

CinRx Pharma develops therapies for unmet needs, leveraging partnerships and expertise to advance new molecular entities.

May 2024
Series B

Founder Contacts

41,000+ verified contacts

Fishers, United States
$42.9M
raised

INCOG BioPharma services include injectable drug product formulation, analytical method, process scale up, and formulation.

May 2024
Series B

Founder Contacts

41,000+ verified contacts

Espoo, Finland
$16.2M
raised

Enifer is a mycoprotein company that produces a fungal fermentation product to upcycle agrifood industry byproducts.

May 2024
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 427 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Abingdon, United Kingdom
$50.0M
raised

We are advancing novel antigen modulation technology that controls T cells to guide the immune system.

May 2024
Series B

Founder Contacts

41,000+ verified contacts

London, United Kingdom
$120.0M
raised

Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers.

May 2024
Series B

Founder Contacts

41,000+ verified contacts

San Carlos, United States
$35.0M
raised

Elegen is a biotechnology company that develops microfluidic technology.

May 2024
Series B

Founder Contacts

41,000+ verified contacts

Wellesley, United States
$24.0M
raised

Qlaris Bio focuses on developing first-in-class therapies for serious and debilitating ophthalmic diseases.

Apr 2024
Series B

Founder Contacts

41,000+ verified contacts

Oxford, United Kingdom
$25.0M
raised

Pathios Therapeutics is a biotech company focused on the development of therapies for autoimmune diseases and cancer.

Apr 2024
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 427 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
San Diego, United States
$132.0M
raised

Alterome Therapeutics is a biopharmaceutical company developing alteration-specific targeted therapies.

Apr 2024
Series B

Founder Contacts

41,000+ verified contacts

Schlieren, Switzerland
$15.6M
raised

Hemotune is a medical device company that develops a therapeutic blood purification platform for the treatment of health ailments.

Mar 2024
Series B

Founder Contacts

41,000+ verified contacts

Richmond, United States
$22.4M
raised

X-Therma is a biotechnology firm that develops a convergent biopreservation platform to advance regenerative medicine.

Mar 2024
Series B

Founder Contacts

41,000+ verified contacts

$29.5M
raised

Infinited Fiber Company is on a mission to make circular fashion and textiles an everyday reality

Mar 2024
Series B

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$62.0M
raised

Nocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation.

Mar 2024
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 427 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Torrance, United States
$35.0M
raised

Athos develops AI-based Precision Therapeutics for patients with Inflammatory Bowel, other Autoimmune Diseases, and cancer.

Feb 2024
Series B

Founder Contacts

41,000+ verified contacts

The Woodlands, United States
$6.6M
raised

Othram aims to revolutionize how forensic cases are solved, justice is served, and families are mended.

Feb 2024
Series B

Founder Contacts

41,000+ verified contacts

Seattle, United States
$112.0M
raised

ProfoundBio is a developer of targeted therapeutics intended for patients with cancer.

Feb 2024
Series B

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$56.0M
raised

Attralus is a biopharmaceutical company focusing on creating transformative medicines to improve the lives of patients.

Feb 2024
Series B

Founder Contacts

41,000+ verified contacts

Seattle, United States
$4.7M
raised

Proniras focuses on development of a new parenteral medical countermeasure (MCM) to treat seizures and brain injury.

Feb 2024
Series B

Founder Contacts

41,000+ verified contacts

Showing 276 to 300 of 427 companies

Ready to Connect with Series B Biotechnology Startups?

Get verified founder emails, funding details, and company data for 427 series b biotechnology companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

427 Biotechnology Series B Startups (October 2026) — Page 12 | VCBacked